Galapagos NV logo
Galapagos NV GLPG
$ 34.61 0.61%

Annual report 2024
added 01-24-2026

report update icon

Galapagos NV P/S Ratio 2011-2026 | GLPG

Annual P/S Ratio Galapagos NV

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - 18.9 14.2 0.0154 18.5 46 340 37.5 7.57 4.33 4.07 -

All numbers in EUR currency

Indicator range from annual reports

Maximum Minimum Average
340 0.0154 49.1

P/S Ratio of other stocks in the Biotechnology industry

Issuer P/S Ratio Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
1.75 - 2.43 % $ 254 M germanyGermany
Adagene Adagene
ADAG
35.6 $ 2.62 28.82 % $ 147 M chinaChina
GlaxoSmithKline plc GlaxoSmithKline plc
GSK
8.36 $ 48.98 0.68 % $ 173 B britainBritain
Acorda Therapeutics Acorda Therapeutics
ACOR
0.142 - -24.86 % $ 820 K usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
7.87 - 5.93 % $ 314 M canadaCanada
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
131 $ 3.51 7.34 % $ 8.45 B australiaAustralia
AgeX Therapeutics AgeX Therapeutics
AGE
0.099 - -10.17 % $ 12.2 K usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.53 - - $ 40.3 B usaUSA
Grifols, S.A. Grifols, S.A.
GRFS
1.71 $ 9.25 1.49 % $ 6.83 B spainSpain
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
489 - - $ 1.01 B usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
1.79 $ 25.92 -0.86 % $ 1.26 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
137 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.39 K - -1.52 % $ 24.7 M usaUSA
Ultragenyx Pharmaceutical Ultragenyx Pharmaceutical
RARE
7.11 $ 24.45 4.49 % $ 2.21 B usaUSA
Aravive Aravive
ARAV
6.61 - -13.39 % $ 1.45 M usaUSA
BioNTech SE BioNTech SE
BNTX
35.7 $ 116.27 -1.86 % $ 27.2 B germanyGermany
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.61 - - - russiaRussia
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
947 $ 235.41 2.95 % $ 5 B danmarkDanmark
BioXcel Therapeutics BioXcel Therapeutics
BTAI
2.37 $ 1.84 1.66 % $ 4.66 M usaUSA
Burford Capital Limited Burford Capital Limited
BUR
6.35 $ 9.74 -1.37 % $ 1.55 B britainBritain
Aytu BioScience Aytu BioScience
AYTU
0.237 $ 2.66 -1.85 % $ 16.7 M usaUSA
Acasti Pharma Acasti Pharma
ACST
0.203 - 4.01 % $ 150 M canadaCanada
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
7.54 $ 67.49 -3.02 % $ 9.03 B usaUSA
Brickell Biotech Brickell Biotech
BBI
1.42 - -5.38 % $ 6.06 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
759 $ 4.51 8.41 % $ 9.81 B israelIsrael
BeiGene, Ltd. BeiGene, Ltd.
BGNE
66.4 - 0.49 % $ 251 B cayman-islandsCayman-islands
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
11.2 - - $ 7.46 M israelIsrael
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
34 - -15.15 % $ 60.3 M britainBritain
AIkido Pharma AIkido Pharma
AIKI
1.08 - 1.93 % $ 17.4 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
13.3 - -0.23 % $ 916 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
281 - - $ 867 M germanyGermany
Acer Therapeutics Acer Therapeutics
ACER
25.8 - 2.71 % $ 14 M usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
5.55 - -9.72 % $ 5.89 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
8.94 - - $ 2.17 B usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
0.813 $ 2.04 28.3 % $ 192 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
106 - -11.43 % $ 502 K usaUSA
Biogen Biogen
BIIB
2 $ 171.89 -1.1 % $ 25 B usaUSA
Bio-Path Holdings Bio-Path Holdings
BPTH
627 - - $ 100 K usaUSA